Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05280366 · ClinicalTrials.gov registry record · NA
STREAMLINE®SURGICAL SYSTEM Compared to iStent Inject W® in Patients With Open-Angle Glaucoma
A NA study of Open Angle Glaucoma, sponsored by New World Medical.
- Active
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 20
- Study locations
NCT05280366: Active NA study of Open Angle Glaucoma, sponsored by New World Medical.
NCT05280366 is a NA study of Open Angle Glaucoma that is active but no longer recruiting, run by New World Medical. The registered enrollment target is 150 participants, below the 329-participant average among 28 other Open Angle Glaucoma trials with a reported enrollment target (54% lower). The trial reports 20 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05280366, a NA study of Open Angle Glaucoma, is active but no longer recruiting, sponsored by New World Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 20
- Study locations
Study Summary
A study of the Streamline Surgical System versus competitor
Conditions Studied
Interventions
- DEVICE Streamline Surgical System
- DEVICE iStent Inject W
Study Locations (20)
Texas
- Ophthalmology Associates - Fort Worth
- Berkely Eye Center - Houston
- R & R Eye Research - San Antonio
California
- Visionary Research Institute - Newport Beach
- Wolstan and Goldberg Eye Associates - Torrance
New Jersey
- Eye Associates of North New Jersey - Dover
- Eye Associates Surgical Center - Vineland
Other
- Clinica 20/20 - San José
- Clinica Laser y Ultrasonido Ocular - Puebla City
Arkansas
- Vold Vision - Fayetteville
Colorado
- University of Colorado - Aurora
Florida
- Ocala Eye - Ocala
Georgia
- Georgia Eye Partners - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2022-02-09 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What the registry record for NCT05280366 still lists
NCT05280366 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 329-participant average among 28 other Open Angle Glaucoma trials with a reported enrollment target (54% lower).
The record links to 1 condition, with Open Angle Glaucoma appearing as the primary indexed condition, and to 2 interventions - of which Streamline Surgical System is the first listed.
NCT05280366 names 20 study sites across 15 states, led by Texas, California, New Jersey.
Frequently Asked Questions
What is clinical trial NCT05280366 about?
NCT05280366 is a clinical study titled "STREAMLINE®SURGICAL SYSTEM Compared to iStent Inject W® in Patients With Open-Angle Glaucoma". A study of the Streamline Surgical System versus competitor
What is the current status of trial NCT05280366?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2022-02-09. Estimated completion is 2026-06-30.
What conditions does trial NCT05280366 study?
This clinical trial studies the following conditions: Open Angle Glaucoma.
What interventions are being tested in trial NCT05280366?
The interventions under investigation include: Streamline Surgical System (DEVICE), iStent Inject W (DEVICE).
Who is sponsoring clinical trial NCT05280366?
This trial is sponsored by New World Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05280366 being conducted?
This trial has 20 study locations across Arkansas, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Open Angle Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05280366's enrollment target sits among peer trials
150 15th of 28 higher than 14 of 28 other Open Angle Glaucoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Open Angle Glaucoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
RECRUITING · NA
-
Surgical Treatment of Refractory Open Angle Glaucoma
COMPLETED · NA
-
24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients
RECRUITING · Phase 4
-
Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost
RECRUITING · Phase 4
-
Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma
RECRUITING · Phase 4
-
A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI